Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population

Clinical Chemistry

Volumn 58, Issue 11, 2012, Pages 1574-1581

  Apple, Fred S ^a,b   Ler, Ranka ^c   Murakami, MaryAnn M ^c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TROPONIN I; TROPONIN T;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LABORATORY TEST; MALE; NORMAL HUMAN; POINT OF CARE TESTING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; SEX RATIO;

ADULT; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TROPONIN I; TROPONIN T; YOUNG ADULT;

EID: 84868089883     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.192716     Document Type: Article

References (32)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation [Epub ahead of print 2012 Aug. 24].
2. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry practice guidelines: clinical characteristics and utilization of biomarkers in acute coronary syndromes. Clin Chem 2007;53:552-74. (Pubitemid 46580223)
3. Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
4. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165-72.
5. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748-54.
6. Apple FS, Simpson PA, Murakami MM. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin Biochem 2010;43:1034-6.
7. Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 32nd-generation assays. Clin Chem 2007;53:1558-60. (Pubitemid 47206361)
8. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003;49:1331-6. (Pubitemid 36900619)
9. Collinson PO, Hwung YM, Gaze D, Boa F, Senior R, Christenson R, Apple FS. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219-25.
10. Apple FS. Standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem 2012;58:169-71.
11. Christenson RH, Bunk DM, Schimmel H, Tate JR, IFCC Working Group on Standardization of Troponin I. Put simply, standardization of cardiac troponin I is complicated. Clin Chem 2012;58:165-8.
12. Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971;17:275-84.
13. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
14. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
15. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009;55:930-7.
16. Apple FS, Smith SW, Pearce LA, Ler R, Allex E, Murakami MM. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54:723-8. (Pubitemid 351573705)
17. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
18. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytical and clinical utility of a next generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-7.
19. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, Van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
20. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
21. Apple FS, Jaffe AS. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem 2012;58:1598-9.
22. Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 trial. Am Heart J 2009;158:386-91.
23. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, et al. Utility of absolute and relative changes in cardiac troponin concentrations in early diagnosis of acute myocardial infarction. Circulation 2011;124:136-45.
24. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209-18.
25. Apple FS, Smith SW, Pearce LA, Murakami MM. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem 2012;45:711-3.
26. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;13:1-8.
27. Collinson PO. Diagnosing myocardial infarction by serial measurement of high sensitivity troponinwhat type of relative change value (delta) and how much should it be? Clin Biochem 2012;45:717-8.
28. Wu A H B, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National academy of clinical biochemistry standards of laboratory practice: recommendations for use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21. (Pubitemid 29340557)
29. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
30. Kontos MC, De Lemos JA, Ou FS, Waviest SD, Foodie J A M, Newby E L K, et al. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: an undertreated but highrisk patient group. Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry. Am Heart J 2010;160:819-25.
31. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs. nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 2007;167:276-81.
32. Apple FS. High-sensitivity cardiac troponin for screening large populations of healthy people: is there risk? Clin Chem 2011;57:537-9.